Today is July 12, 2024.
All times in Eastern Daylight Time.
-
Amprius Signs Multiple Contract Manufacturing Partnerships to Secure Over 500 MWh of Production Capacity for SiCore™ Cells
FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. (“Amprius”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced a strategic... more »
-
Allstate Announces May 2024 Catastrophe Losses
NORTHBROOK, Ill.--(BUSINESS WIRE)--The Allstate Corporation (NYSE: ALL) today announced estimated catastrophe losses for the month of May of $1.40 billion or $1.10 billion, after-tax. Catastrophe l... more »
-
Coya Therapeutics Expands Sponsored Research Collaboration with Houston Methodist Research Institute Along with Funding from the Johnson Center for Cellular Therapeutics to Advance Regulatory T Cell Exosome Platform into the Clinic
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) ... more »
-
Stratasys and BASF Partner to Deliver New Polypropylene Material for Stratasys SAF Technology
EDEN PRAIRIE, Minn. & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (Nasdaq: SSYS) today announced the commercial availability of its groundbreaking new material, SAF™ Polypropylene (PP)for use ... more »
-
TD SYNNEX Announces Patrick Zammit to Become CEO
FREMONT, Calif., & CLEARWATER, Fla.--(BUSINESS WIRE)--TD SYNNEX announced that Patrick Zammit will become Chief Executive Officer, succeeding Rich Hume, who will retire after a transformative CEO t... more »
-
CommScope Updates E6000 Converged Edge Router with Key New Features
CLAREMONT, N.C.--(BUSINESS WIRE)--CommScope (NASDAQ: COMM), announced today the availability of Software Release 13 for the E6000® Converged Edge Router (CER). more »
-
Alto Neuroscience Initiates Phase 2 Study of ALTO-101, a Novel PDE4 Inhibitor, in Cognitive Impairment Associated with Schizophrenia
LOS ALTOS, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the initiation of a Phase 2 double-blind, placebo-controlled study of its transdermal formulation o... more »
-
Weave Ranks Among Highest-Scoring Businesses on Inc.’s Annual List of Best Workplaces for 2024
LEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one experience platform for small- and medium-sized healthcare businesses, has been named to Inc.’s annual Best Workplaces list. Th... more »
-
UiPath Issues Fiscal Year 2024 Impact Report
NEW YORK--(BUSINESS WIRE)--UiPath released its Fiscal Year 2024 Impact Report, highlighting progress within the dimensions of its ESG approach. more »
-
Mosaic Insurance Partners with WNS on Future-ready Operations Model
NEW YORK & LONDON & HAMILTON, Bermuda & MUMBAI, India--(BUSINESS WIRE)--WNS (Holdings) Limited and Mosaic Insurance today announced their strategic partnership to create a future-ready operations m... more »
-
MicroStrategy Completes $800 Million Offering of 2.25% Convertible Senior Notes Due 2032
TYSONS CORNER, Va.--(BUSINESS WIRE)--MicroStrategy® Incorporated (Nasdaq: MSTR) (“MicroStrategy”) today announced that, on June 18, 2024, it completed its previously announced offering of 2.25% con... more »
-
GRF Sampling Highest Performing Broadband Gain Block to Date, Stretching Performance of Its Leading Amp Core to 11 GHz
GREENSBORO, N.C.--(BUSINESS WIRE)--GRF sampling highest performing broadband gain block to date, stretching performance of its leading amp core to 11 GHz. more »
-
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (... more »
-
Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease ... more »
-
Mobix Labs Collaborates to Develop Low-Cost, Energy-Efficient 5G Base Station Solutions
IRVINE, Calif.--(BUSINESS WIRE)--Mobix Labs Inc. (Nasdaq: MOBX), a fabless semiconductor company specializing in next-generation connectivity solutions, today announced a strategic partnership with... more »
-
Zebra Study: Only 16% of Manufacturers Have Real-Time Visibility into Manufacturing Production
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Zebra Technologies announces the findings of its 2024 Manufacturing Vision Study. more »
-
Adtran joins LU-CIX community as a Gold Member
BETTEMBOURG, Luxembourg--(BUSINESS WIRE)--Adtran and the Luxembourg Internet eXchange (LU-CIX), today announced that Adtran has joined the LU-CIX community as a Gold Member. This addition expands a... more »
-
Redfin Reports Home Prices Hit New High, But Buyers Gain Power as Stale Listings Pile Up and Price Drops Become More Common
SEATTLE--(BUSINESS WIRE)--(NASDAQ: RDFN) — Pending home sales fell 3.8%, the biggest year-over-year decline in nearly four months, during the four weeks ending June 16. That’s according to a new re... more »
-
NICE’s Inaugural International Happiness Index Finds 78% of People Think Leveraging AI In Customer Service Can Make Them Happier Consumers
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE (Nasdaq: NICE) today announced the release of the 2024 International Happiness Index, its groundbreaking, inaugural research which highlights the opportunity ga... more »
-
Reimagining Messaging in the Generative AI Era, Former ExactTarget Executive Starts Backstroke
INDIANAPOLIS--(BUSINESS WIRE)--Backstroke is announcing the launch of its generative AI messaging platform that’s set to revolutionize email, SMS, mobile push, and customer marketing for B2C brands... more »
-
Kiromic BioPharma Provides Updates on its Deltacel-01 Clinical Trial
HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) reports follow-up results from the second, third and fourth patients enrolled in its Deltacel-01 Phase 1... more »
-
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study demonstrating an average lean mass gain o... more »
-
BARK Leads Development of First-Ever Industry-Wide Dog Toy Safety Standard
NEW YORK--(BUSINESS WIRE)--BARK (NYSE: BARK), a leading global omnichannel dog brand on a mission to make all dogs happy, today announced its pivotal role in developing the pet product industry's f... more »
-
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces t... more »
-
BEST Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of BEST Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of BEST Inc. (NYSE: BEST) to BEST Global Partners and Phoenix Global Partners for $2.88 i... more »
|
|